Literature DB >> 33992487

On-admission parameters based prognostication in COVID-19: an important missing link….

Rohan Magoon1, Jes Jose2.   

Abstract

Entities:  

Keywords:  Blood glucose; COVID-19; Hyperglycaemia; On-admission parameters; Prognostication

Year:  2021        PMID: 33992487      PMCID: PMC8106198          DOI: 10.1016/j.ajem.2021.05.015

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


× No keyword cloud information.
Dear Editor, We read with great interest the research report by Oh et al. highlighting the on-admission anemia as an important predictor of all-cause mortality in a retrospective evaluation of 733 adult COVID-19 patients [1]. While early and parsimonious prognostication in COVID-19 is doubtlessly the need of the hour albeit an important missing link in their analysis merits elucidation. The lack of presentation of the blood glucose levels in the index study captivates attention, particularly when there is an accumulating literature on the prognostic role of the on-admission hyperglycaemia in COVID-19 regardless of the diabetic status of the diseased subset [[2], [3], [4]]. In this context, a systematic review and dose-response meta analysis by Lazarus et al. (comprising of 35 studies and a total of 14,502 patients) reveal a 33% accentuation in the risk of COVID-19 disease severity for every 1 mmol/L increase in the on-admission fasting blood glucose [2]. The subsequent GRADE assessment tool yielded a high quality evidence for the fasting blood glucose association with a severe disease, and a moderate quality evidence for the resulting association with mortality and/or poor outcomes [2]. Needless to say, the stress-induced hyperglycaemic response is expected to exacerbate the ongoing COVID-19 related endothelial dysfunction, oxidative-stress, pro-inflammatory and pro-thrombotic milieu [[5], [6], [7]]. Herein, acute hyperglycaemia can understandably be peculiarly detrimental in the absence of defence mechanisms which develop to mitigate the oxidative stress owing to chronic hyperglycaemia [8]. Withstanding the abovementioned fact, many researchers suggest a rather adverse outcome with on-admission hyperglycaemia in the non-diabetics when compared to the diabetic counterparts [8]. Therefore, the authors' isolated account of the diabetic status of the included patients is far from holistic [1]. To conclude, stress hyperglycaemia is intricately linked to the outcomes in the critically ill [9], COVID-19 cohort being no exception [8]. As much as the authors need to be applauded for their research endeavours, missing out on the prognostic role of routine parameters such as on-admission glycaemia can definitely not be overlooked.

Author roles

RM conceptualized and wrote the entire comment. JJ searched the literature.

Declaration of competing interest

We do not have any conflict of interest, any commercial or financial interest in this material & agree to abide by the rules of your journal regarding publication of this article.
  9 in total

1.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.

Authors:  James Stephen Krinsley
Journal:  Mayo Clin Proc       Date:  2003-12       Impact factor: 7.616

2.  On-admission anemia predicts mortality in COVID-19 patients: A single center, retrospective cohort study.

Authors:  Seung Mi Oh; John P Skendelas; Eric Macdonald; Michael Bergamini; Swati Goel; Jaeun Choi; Kathryn R Segal; Kumar Vivek; Singh Nair; Jonathan Leff
Journal:  Am J Emerg Med       Date:  2021-03-29       Impact factor: 4.093

3.  High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis.

Authors:  Gilbert Lazarus; Jessica Audrey; Vincent Kharisma Wangsaputra; Alice Tamara; Dicky L Tahapary
Journal:  Diabetes Res Clin Pract       Date:  2020-12-09       Impact factor: 5.602

4.  Inhaled milrinone for sick COVID-19 cohort: A pathophysiology driven hypothesis!

Authors:  Rohan Magoon; Jasvinder Kaur Kohli; Ramesh Kashav
Journal:  Med Hypotheses       Date:  2020-11-29       Impact factor: 1.538

5.  Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.

Authors:  Sufei Wang; Pei Ma; Shujing Zhang; Siwei Song; Zhihui Wang; Yanling Ma; Juanjuan Xu; Feng Wu; Limin Duan; Zhengrong Yin; Huilin Luo; Nian Xiong; Man Xu; Tianshu Zeng; Yang Jin
Journal:  Diabetologia       Date:  2020-07-10       Impact factor: 10.122

6.  Fasting blood glucose level is a predictor of mortality in patients with COVID-19 independent of diabetes history.

Authors:  Yuli Cai; Shaobo Shi; Fan Yang; Bo Yi; Xiaolin Chen; Junfeng Li; Zhongyuan Wen
Journal:  Diabetes Res Clin Pract       Date:  2020-09-10       Impact factor: 5.602

7.  COVID-19 and congenital heart disease: Cardiopulmonary interactions for the worse!

Authors:  Rohan Magoon
Journal:  Paediatr Anaesth       Date:  2020-10       Impact factor: 2.556

8.  Pulmonary vasculature in COVID-19: mechanism to monitoring!

Authors:  Rohan Magoon
Journal:  Korean J Anesthesiol       Date:  2020-10-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.